by Carolyn Haywood | Aug 1, 2017 | Briefings, UK
The recent interim Patents Court decision of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy’s Laboratories (2) Sandoz Limited (and others) [2017] EWHC 1433 (Pat) provides guidance on how the court calculates damages associated with an interim injunction and...
by David Eyre | Jul 1, 2017 | UK
The overriding objective of the court system according to the civil procedure rules is that the court is able to deal with cases justly and at proportionate cost. It has long been a concern that justice might be denied to small entities pursuing patent claims because...
by Alex Bajjon | Jun 1, 2017 | UK
Background According to Article 3(a) of the SPC Regulation (European Parliament and Council Regulation 469/2009/EC of 6 May 2009 concerning the supplementary protection certificate for medicinal products) an SPC shall be granted for a medicinal product if the product...
by Sean Hughes | May 1, 2017 | UK
Background For more information on Arrow Declarations, please read Part I and Part II of this series of articles. In September 2016, Mr Justice Arnold refused to strike out Fujifilm’s request for an Arrow Declaration, at the request of AbbVie, based on bad faith...
Recent Comments